Novartis AG (ADR) (NVS): Are Hedge Funds Right About This Stock?

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
GlaxoSmithKline plc (ADR) (NYSE:GSK) 18 0 0
Merck & Co., Inc. (NYSE:MRK) 56 0 4
Sanofi SA (ADR) (NYSE:SNY) 53 0 0
Johnson & Johnson (NYSE:JNJ) 65 0 2
Pfizer Inc. (NYSE:PFE) 81 0 11

With the results demonstrated by the aforementioned strategies, everyday investors should always watch hedge fund and insider trading activity, and Novartis AG (ADR) (NYSE:NVS) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

Page 2 of 2